We represented Havencrest Capital Management, a Dallas-based, private equity fund manager specializing in the healthcare industry, in its acquisition of Tekton, a clinical trial site network with 23 sites across Texas, Colorado, Georgia, Kansas, and Oklahoma. Terms of the transaction were not disclosed.